Oral cancer, HPV infection and evidence of sexual transmission

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 18, Issue 3, 2013, Pages

  Martín Hernán, Fátima ^a   Sánchez Hernández, Juan Gabriel ^a   Cano, Jorge ^a   Campo, Julián ^a   del Romero, Jorge ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Sandoval Sexually Transmitted Diseases   (Spain)

Author keywords

Head and neck cancer; Human papillomavirus; Oral cancer; Oral sex; Oropharyngeal cancer; Squamous cell carcinoma

Indexed keywords

CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; HISTOLOGY; HUMAN; IN SITU HYBRIDIZATION; METASTASIS; MOUTH CANCER; MOUTH INFECTION; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; RISK FACTOR; SEXUAL TRANSMISSION;

HUMANS; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 84877088476     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.18419     Document Type: Review

References (35)

1. Marur S, D'Souza G, Westra WH, Forastiere AA. HPVassociated heck and neck cancer: a virusrelated cancer epidemic. Lancet Oncol. 2010; 11: 781-9.
2. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol. 2008; 19: 1681-90.
3. Syrjänen S. The role of human papillomavirus infection in head and neck cancers. Ann Oncol. 2010; 21 Suppl 7: 243-5.
4. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, et al. Human Papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003; 104: 336-40.
5. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal asociation between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-20.
6. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta-Analysis of the impact of Human Papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head & Neck Oncology. 2010; 2:15.
7. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral-Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91:622-35.
8. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum A, et al. Distinct risk factor profiles for human papillomavirus type-16 positive and human papilomavirus type-16 negative head and neck cancers. J Natl Cancer Inst. 2008; 100:407-20.
9. Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh - Hung V. Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. QJM. 2010; 103: 229-36.
10. Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the internacional agency for research on cancer multicenter study. J Natl Cancer Inst. 2003; 95: 1772-83.
11. D'Souza G, Zhang HH, D'Souza WD, Meyer RR, Gillison ML. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 2010; 46:100-4.
12. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma. Increasing trends in the U.S population ages 20-44 years. Cancer. 2005; 103: 1843-9.
13. Tachezy R, Klozar J, Saláková M, Smith E, Turek L, Betka J, et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis. 2005; 11:181-5.
14. Chocolatewala NM, Chaturvedi P. Role of human papiloma virus in the oral carcinogenesis: An Indian perspective. J Cancer Res Ther. 2009; 5:71-7.
15. Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LP. Prevalence of human papillomavirus in the oral cavity/ oropharynx in a large population of children and adolescents. Pediatr Infect Dis J. 2007; 26:836-40.
16. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirusassociated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006; 24: 736-47.
17. Ljubojević S. The human papillomavirus vaccines. Acta Dermatovenerol Croat. 2006; 14:208.
18. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. 2004; 189:686-98.
19. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009; 199:1263-9.
20. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356:1944-56.
21. Brondani M. HPV, oral sex, and the risk of oral cancer: food for thought. Spec Care Dentist. 2008; 28:183-4.
22. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010; 39:166-81.
23. Forster A, Wardle J, Stephenson J, Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun. 2010; 15:205-17.
24. Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg. 2009; 135:402-5.
25. Acha-Sagredo A, Ruesga MT, Aguirregaviria JI, Aguirre Urizar JM. Infección por VPH y carcinogénesis oral. Med Oral Patol Oral Cir Bucal.2010; 15:e1-2.
26. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55: 244-65.
27. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. High risk papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006; 24: 5630-6.
28. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al. EFGR, p16, HPV Titer, Bclxl and p53, sex and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008; 26: 3128-37.
29. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomaviruspositive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-9.
30. Dahlstrom KR, Li G, Tortolero-Luna G, Wei Q, Sturgis EM. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011;33:847-55.
31. Baden LR, Curfman GD, Morrissey S, Drazen JM. Human Papillomavirus VaccineOpportunity and Challenge. N Engl J Med. 2007; 356: 1990-1.
32. Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR. Efficacy of human papillomavirus vaccines: a systematic quantitative review. Int J Gynecol Cancer. 2009; 19:1166-76.
33. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. 2008; 26 Suppl 10:53-61.
34. Lugarini J, Maddalo F. Results of a vaccination campaign against human papillomavirus in the province of La Spezia, Liguria, Italy, March-December 2008. Euro Surveill. 2009; 14. pii: 19342.
35. Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010; 141: 509-20.